Enterprise Value

-26.51M

Cash

119.2M

Avg Qtr Burn

-6.453M

Short % of Float

6.83%

Insider Ownership

0.20%

Institutional Own.

62.40%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Fasedienol (PH94B) Details
Social Anxiety Disorder

Phase 3

Data readout

Phase 2b

Initiation

PH80 ( nasal spray ) Details
Menopause, Hot flashes

Phase 2b

Initiation

Phase 2a

Update

Phase 2a

Update

Phase 2a

Update